Literature DB >> 31760109

Integrated Behavioral Treatment for Veterans With Co-Morbid Chronic Pain and Hazardous Opioid Use: A Randomized Controlled Pilot Trial.

Kevin E Vowles1, Katie Witkiewitz2, Karen J Cusack3, Wesley P Gilliam4, Karen E Cardon3, Sarah Bowen5, Karlyn A Edwards1, Mindy L McEntee6, Robert W Bailey7.   

Abstract

Opioid prescription in the treatment of chronic pain is frequent and carries a risk of increased morbidity and mortality in a clinically significant number of patients, particularly those who are using opioids in a hazardous manner. Few treatment options are available that target both pain-related interference and hazardous opioid use among patients with chronic pain. In military Veterans, this issue is of particular importance as numerous reports indicate continued high rates of opioid prescription for chronic pain, as well as significant opioid-related problems. The overall aim of the present study was to determine the feasibility of an integrated psychosocial treatment in Veterans with chronic pain, who also have evidence of hazardous opioid use. To examine this aim, a random design was used to assess the feasibility and initial efficacy of integrating 2 empirically supported interventions: Acceptance and Commitment Therapy for chronic pain and Mindfulness Based Relapse Prevention for opioid misuse. Half of participants were randomized to the integrated treatment group and all participants received usual care through a Veteran's Administration co-occurring disorders medical clinic to treat chronic pain and opioid misuse. In total, 37 participants were randomized and included in intent-to-treat analyses and 32 individuals were included in per protocol analyses with 6-month follow-up serving as the primary study endpoint. Feasibility indicators included recruitment, retention, and treatment completion rates. Recruitment fell short of targeted enrollment, although retention and completion were excellent. Primary outcome measures were opioid misuse, pain interference, and pain behavior. Simultaneous multiple regression analyses controlled for pain duration, baseline opioid dose, and baseline value for outcome measures. Results of both the intent-to-treat and per protocol indicated a significant effect in favor of the integrated intervention for opioid misuse, pain interference, and pain behavior. Results support the feasibility of providing an integrated treatment for both opioid risk and pain interference. PERSPECTIVE: Opioid misuse occurs in some opioid-prescribed individuals with chronic pain. Few treatment options exist that target both pain interference and opioid misuse. This study examined feasibility and initial efficacy of an integrated behavioral treatment for Veterans. Feasibility was supported, except recruitment. Efficacy was supported compared to usual care.
Copyright © 2019 United States Association for the Study of Pain, Inc. All rights reserved.

Entities:  

Keywords:  Chronic pain; acceptance and commitment therapy; integrated treatment; mindfulness-based relapse prevention; opioids; veterans

Year:  2019        PMID: 31760109      PMCID: PMC7542006          DOI: 10.1016/j.jpain.2019.11.007

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  54 in total

1.  An analysis of within-treatment change trajectories in valued activity in relation to treatment outcomes following interdisciplinary Acceptance and Commitment Therapy for adults with chronic pain.

Authors:  Kevin E Vowles; Gail Sowden; Jayne Hickman; Julie Ashworth
Journal:  Behav Res Ther       Date:  2018-10-27

2.  Chronic pain prevalence and analgesic prescribing in a general medical population.

Authors:  J David Clark
Journal:  J Pain Symptom Manage       Date:  2002-02       Impact factor: 3.612

Review 3.  The efficacy of Acceptance and Commitment Therapy: an updated systematic review and meta-analysis.

Authors:  Lars-Göran Ost
Journal:  Behav Res Ther       Date:  2014-08-19

4.  Development of a PROMIS item bank to measure pain interference.

Authors:  Dagmar Amtmann; Karon F Cook; Mark P Jensen; Wen-Hung Chen; Seung Choi; Dennis Revicki; David Cella; Nan Rothrock; Francis Keefe; Leigh Callahan; Jin-Shei Lai
Journal:  Pain       Date:  2010-07       Impact factor: 6.961

5.  Veterans' reports of pain and associations with ratings of health, health-risk behaviors, affective distress, and use of the healthcare system.

Authors:  Robert D Kerns; John Otis; Roberta Rosenberg; M Carrington Reid
Journal:  J Rehabil Res Dev       Date:  2003 Sep-Oct

6.  Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Authors:  Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

7.  Development and psychometric analysis of the PROMIS pain behavior item bank.

Authors:  Dennis A Revicki; Wen-Hung Chen; Neesha Harnam; Karon F Cook; Dagmar Amtmann; Leigh F Callahan; Mark P Jensen; Francis J Keefe
Journal:  Pain       Date:  2009-08-15       Impact factor: 6.961

8.  Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society.

Authors:  Roger Chou; Amir Qaseem; Vincenza Snow; Donald Casey; J Thomas Cross; Paul Shekelle; Douglas K Owens
Journal:  Ann Intern Med       Date:  2007-10-02       Impact factor: 25.391

9.  Using Analgesics for Emotional Modulation is Associated With Increased Distress, Depression, and Risk of Opioid and Alcohol Misuse: Initial Evaluation and Component Analysis of the Reasons for Analgesic Use Measure (RAUM).

Authors:  Kevin E Vowles; Robert W Bailey; Mindy L McEntee; Melissa Pielech; Karlyn A Edwards; Lena A Bolling; W Evan Rivers
Journal:  Clin J Pain       Date:  2018-10       Impact factor: 3.442

10.  Acceptance and commitment therapy for chronic pain: evidence of mediation and clinically significant change following an abbreviated interdisciplinary program of rehabilitation.

Authors:  Kevin E Vowles; Katie Witkiewitz; Gail Sowden; Julie Ashworth
Journal:  J Pain       Date:  2013-10-17       Impact factor: 5.820

View more
  4 in total

Review 1.  Mindfulness-based interventions for substance use disorders.

Authors:  Simon B Goldberg; Brian Pace; Matas Griskaitis; Reinhard Willutzki; Nicole Skoetz; Sven Thoenes; Aleksandra E Zgierska; Susanne Rösner
Journal:  Cochrane Database Syst Rev       Date:  2021-10-20

2.  Addictive Behavior Change and Mindfulness-Based Interventions: Current Research and Future Directions.

Authors:  Frank J Schwebel; J Richard Korecki; Katie Witkiewitz
Journal:  Curr Addict Rep       Date:  2020-02-15

Review 3.  Nonpharmacologic Treatments for Opioid Reduction in Patients With Advanced Chronic Kidney Disease.

Authors:  Carrie E Brintz; Martin D Cheatle; Laura M Dember; Alicia A Heapy; Manisha Jhamb; Amanda J Shallcross; Jennifer L Steel; Paul L Kimmel; Daniel Cukor
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 4.472

4.  Advanced models for improved prediction of opioid-related overdose and suicide events among Veterans using administrative healthcare data.

Authors:  Ralph Ward; Erin Weeda; David J Taber; Robert Neal Axon; Mulugeta Gebregziabher
Journal:  Health Serv Outcomes Res Methodol       Date:  2021-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.